Table 4.

Basal level of FFA and PAI-1, on the 1st and 12th days from the MI, respectively

Variables	Control (n = 30)	Patients with MI (n = 65)		Patients with MI and type 2 diabetes mellitus (n = 60)
		1st day	12th day	1st day	12th day
FFA, mmol/L	0.20 (0.1; 1.1)	1.41 (0.93; 1.92)*,#	0.61 (0.41; 0.87)**,#	2.20 (1.47; 2.78)*	0.93 (0.68; 1.28)**
PA-1, ng/mL	35.25 (28.3; 46.3)	86.44 (64.36; 136.20)*,#	71.21 (37.61; 102.10)**,#	161.09 (131.15; 177.00)*	107.64 (74.81; 166.40)**

Notes: The results are presented as median and quartiles (Me [Q1;Q₃]).

^*Reliable differences from controls, (P < 0.05);

^**reliable differences in the indicators on the 1st and 12th day (P < 0.05);

^#reliable differences among patients with both MI and type 2 diabetes and among patients without type 2 diabetes mellitus (P < 0.05).

Abbreviations: FFA, free fatty acid; MI, myocardial infarction; PAI-1, plasminogen activator inhibitor-1.